Print

Print


Manganese increases L-DOPA auto-oxidation in the striatum of the freely
moving rat:
potential implications to L-DOPA long-term therapy of Parkinson's disease.

We have previously shown that manganese enhances L-dihydroxyphenylanine
(L-DOPA) toxicity to PC12 cells in vitro.

The supposed mechanism of manganese enhancing effect [an increase in L-DOPA
and dopamine (DA) auto-oxidation] was studied using microdialysis in the
striatum of freely moving rats.

Systemic L-DOPA [25 mg kg(-1) intraperitoneally (i.p.) twice in a 12 h
interval] significantly increased baseline dialysate concentrations of
L-DOPA, dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and
uric acid, compared to controls.

Conversely, DA and ascorbic acid concentrations were significantly
decreased. A L-DOPA oxidation product, presumptively identified as L-DOPA
semiquinone, was detected in the dialysate.

The L-DOPA semiquinone was detected also following intrastriatal infusion
of L-DOPA.

In rats given L-DOPA i.p. , intrastriatal infusion of N-acetylcysteine
(NAC) significantly increased DA and L-DOPA dialysate concentrations and
lowered those of L-DOPA semiquinone; in addition, NAC decreased DOPAC+HVA
and uric acid dialysate concentrations.

In rats given L-DOPA either systemically or intrastriatally, intrastriatal
infusion of manganese decreased L-DOPA dialysate concentrations and greatly
increased those of L-DOPA semiquinone.

These changes were inhibited by NAC infusion.

These findings demonstrate that auto-oxidation of exogenous L-DOPA occurs
in vivo in the rat striatum.

The consequent reactive oxygen species generation may account for the
decrease in dialysate DA and ascorbic acid concentrations and increase in
enzymatic oxidation of xanthine and DA.

L-DOPA auto-oxidation is inhibited by NAC and enhanced by manganese.

These results may be of relevance to the L-DOPA long-term therapy of
Parkinson's disease.


Br J Pharmacol 2000 Jun;130(4):937-45
Serra PA, Esposito G, Enrico P, Mura MA, Migheli R,
Delogu MR, Miele M, Desole MS, Grella G, Miele E
Department of Pharmacology, University of Sassari, 07100 Sassari, Italy.
PMID: 10864903, UI: 20325006

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list
_uids=10864903&dopt=Abstract


janet paterson
53 now / 44 dx cd / 43 onset cd / 41 dx pd / 37 onset pd
TEL: 613 256 8340 URL: http://www.geocities.com/janet313/
EMAIL: [log in to unmask] SMAIL: PO Box 171 Almonte Ontario K0A 1A0 Canada